Highly accomplished scientist with 10 years industry experience in Biotherapeutics. Drug discovery experience spanning from therapeutic hybridoma early discovery through to lead selection and CHO stable pool generation. Independently established development production capacity, delivering >20 grams of antibody for 6 clinical studies within 1 year. Optimized cloning, nucleofection, and stable pool selection, including miniaturization to 96 well format, resulting in significantly shorter timelines and increased antibody titer. Extensive experience with Flow Cytometry, including the establishment, execution, and analysis of 8 multi-color panels for canine lymphoma samples, resulting in confirmed B cell and T cell diagnoses for client owned animals. Organized and detail-oriented with well-developed interpersonal skills including experience managing associates in a cooperative team environment. Coordinates with management and interfaces with cross-functional teams in the daily execution of tasks. Able to independently design and execute experiments to achieve aggressive target deadlines and objectives, while maintaining high quality lab notebook records and complying with regulations and policies.
Principal Scientist, Protein Expression Lead at Velia
Masters Degree, Molecular, Cellular, Developmental Biology